T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis

Volume: 9, Issue: 7, Pages: 772 - 772
Published: Jul 2, 2021
Abstract
Although bronchiectasis pathophysiology has been historically understood around the presence of airway neutrophilic inflammation, recent experiences are consistent with the identification of a type 2 inflammation (T2) high endotype in bronchiectasis. In order to evaluate prevalence and clinical characteristics of bronchiectasis patients with a T2-high endotype and explore their response to biologicals, two studies were carried out. In a...
Paper Details
Title
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
Published Date
Jul 2, 2021
Volume
9
Issue
7
Pages
772 - 772
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.